Abstract:Key PointsSignal transducer and activator of transcription (STAT) proteins have dual roles: they transduce signals through the cytoplasm and function as transcription factors in the nucleus. Although some STAT proteins such as STAT1 increase anti-tumour immunity, STAT3 and others induce cancer-promoting inflammation.STAT3 signalling is a major intrinsic pathway for cancer inflammation owing to its frequent activation in malignant cells and key role in regulating many genes crucial for cancer inflammation in the tumour microenvironment.Persistent activation of STAT3, and to a lesser extent STAT5, in diverse human cancers increases proliferation, survival, angiogenesis and metastasis, while also inhibiting anti-tumour immunity.Many STAT3-regulated genes encode cytokines and growth factors, the receptors of which in turn activate the same STAT3 pathways, thereby propagating a stable feedforward loop between tumour cells and non-transformed stromal cells, including myeloid cells and T cells, promoting inflammatory responses that further support tumour growth and survival.Interleukin-6 (IL-6)–Janus kinase (JAK)–STAT3 signalling is important for cancers resulting from the activation of the intrinsic inflammatory pathway owing to genetic or epigenetic changes in tumour cells. Extrinsic environmental inflammatory factors such as sunlight, pathogens and chemical carcinogens can also activate STAT3 through different mechanisms.STAT3 interacts with nuclear factor-κB (NF-κB) at multiple levels and is activated by several NF-κB-regulated gene products, including IL-6. These two transcription factors regulate a multitude of genes important for STAT3 activation and cancer-promoting inflammation.STAT1-driven anti-tumour immune responses and STAT3-mediated immune modulatory pathways can be mutually antagonistic, suggesting that therapeutic interventions targeting specific STATs can tip this balance to convert tumour-promoting inflammation to anti-tumour immune responses. Therefore, STAT3 has emerged as a crucial target for cancer therapy and STAT3 inhibitors are actively being developed.Several tyrosine kinase inhibitors already in the clinic reduce STAT3 signalling by various mechanisms, thereby inducing tumour cell apoptosis and modulating inflammation in the tumour microenvironment in favour of therapeutic responses.

HIPK2 directs cell type–specific regulation of STAT3 transcriptional activity in Th17 cell differentiation

Abstract 5511: Lineage-specific and Shared Cytokine-Sensing Genes Respond Distinctly to the Master Regulator STAT5

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity

Genome-wide Analysis of STAT3-Mediated Transcription During Early Human Th17 Cell Differentiation.

Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

CIP2A Constrains Th17 Differentiation by Modulating STAT3 Signaling

Selective Sequestration of STAT1 in the Cytoplasm Via Phosphorylated SHP-2 Ameliorates Murine Experimental Colitis

STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response

TCR Signaling Induces STAT3 Phosphorylation to Promote TH17 Cell Differentiation.

A STAT3 palmitoylation cycle promotes TH17 differentiation and colitis

Heme Oxygenase-1 Directly Binds Stat3 To Control The Generation Of Pathogenic Th17 Cells During Neutrophilic Airway Inflammation

Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity Via the Regulation of Ectonucleotidase Expression.

The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates T H 17 differentiation

Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.

STATs in cancer inflammation and immunity: a leading role for STAT3

LKB1 isoform expression modulates T cell plasticity downstream of PKCθ and IL-6

Interleukin-2 Signaling Via STAT5 Constrains T Helper 17 Cell Generation.

STAT3 in regulating Th17 differentiation and its relationship with autoimmune hematological diseases

Role of Smad and Non-Smad Signals in the Development of Th17 and Regulatory T Cells (49.3)

Pseudokinase STK40 Promotes T H 1 and T H 17 Cell Differentiation by Targeting FOXO Transcription Factors